CIK 0001799788 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -19.4 M | -8.9 M | -7.8 M |
| Diluted EPS (USD/shares) | -1.43 | -0.69 | -0.61 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-11 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-30 | 4 | 4 | 2026-07-28 |
| 2026-07-29 | 4 | 4 | 2026-07-27 |
| 2026-07-27 | 4 | 4 | 2026-07-23 |
| 2026-06-04 | 10-Q | 10-Q | 2026-03-31 |
| 2026-06-01 | 10-K | 10-K | 2025-12-31 |
| 2026-03-31 | NT 10-K | NT 10-K | 2025-12-31 |
| 2026-01-15 | 4 | 4 | 2026-01-13 |
| 2026-01-14 | 4 | 4 | 2026-01-12 |
| 2026-01-05 | 4 | 4 | 2025-12-31 |
| 2026-01-02 | 4 | 4 | 2025-12-30 |
| 2025-12-19 | 4 | 4 | 2025-12-18 |
| 2025-12-18 | 8-K | 8-K items 5.07 | 2025-12-18 |
| 2025-11-28 | 4 | 4 | 2025-11-25 |
| 2025-11-17 | 4 | 4 | 2025-11-13 |
| 2025-11-14 | 10-Q | 10-Q | 2025-09-30 |
| 2025-11-12 | 4 | 4 | 2025-11-07 |
| 2025-11-04 | 4 | 4 | 2025-10-31 |
| 2025-11-03 | ARS | ARS | 2024-12-31 |
| 2025-11-03 | DEFA14A | DEFA14A | |
| 2025-11-03 | DEF 14A | DEF 14A | 2025-11-03 |
| 2025-08-14 | 10-Q | 10-Q | 2025-06-30 |
| 2025-07-24 | 8-K | 8-K items 4.01,9.01 | 2025-07-19 |
| 2025-05-20 | 10-Q | 10-Q | 2025-03-31 |
| 2025-05-15 | NT 10-Q | NT 10-Q | 2025-03-31 |
Forms on file (last 1,000): 4 135, 8-K 31, 10-Q 18, 3 9, CORRESP 9, UPLOAD 7, 10-K 6, NT 10-Q 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=GLSI (0.002 USD), /gw/filings/filings?ticker=GLSI&form=8-K, /gw/filings/facts?ticker=GLSI&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange